89BIO (ETNB)
(Delayed Data from NSDQ)
$7.36 USD
-0.04 (-0.54%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $7.35 -0.01 (-0.14%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.54 |
EPS Last Quarter | -0.48 |
Last EPS Surprise | 14.29% |
ABR | 1.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.32 |
Next Year | -2.70 |
EPS (TTM) | -1.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.54 | -0.59 | -2.32 | -2.70 |
# of Estimates | 4 | 4 | 6 | 5 |
Most Recent Consensus | -0.52 | -0.55 | -2.78 | -2.36 |
High Estimate | -0.51 | -0.53 | -2.06 | -2.25 |
Low Estimate | -0.61 | -0.73 | -2.78 | -3.20 |
Year ago EPS | -0.45 | -0.50 | -2.00 | -2.32 |
Year over Year Growth Est. | -20.00% | -18.00% | -16.00% | -16.31% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.54 | -0.59 | -2.32 | -2.70 |
7 Days Ago | -0.54 | -0.59 | -2.32 | -2.70 |
30 Days Ago | -0.54 | -0.59 | -2.32 | -2.70 |
60 Days Ago | -0.59 | -0.62 | -2.42 | -3.06 |
90 Days Ago | -0.59 | -0.62 | -2.42 | -3.06 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.54 | -0.59 | -2.49 | -2.99 |
Zacks Consensus Estimate | -0.54 | -0.59 | -2.32 | -2.70 |
Earnings ESP | 0.00% | 0.00% | -7.25% | -10.74% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.48 | -0.54 | -0.50 | -0.45 | NA |
Estimate | -0.56 | -0.48 | -0.53 | -0.50 | NA |
Difference | 0.08 | -0.06 | 0.03 | 0.05 | 0.03 |
Surprise | 14.29% | -12.50% | 5.66% | 10.00% | 4.36% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more